Via EGFR signaling and EMT, 1,3-N-acetylglucosamine transferase 3 catalyzes the increase in interaction with PD-1 in triple-negative breast cancer [50,51]. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.